Innovation Grant in the Brazilian Pharmaceutical Sector:

An Analysis from the Level of Uncertainty

Authors

  • Luiza Pinheiro UFMG
  • Márcia Siqueira Rapini Cedeplar/UFMG
  • Julia Paranhos IE/UFRJ

DOI:

https://doi.org/10.20401/rasi.7.1.520

Keywords:

Public Grants; FINEP; Pharmaceutical Sector; Uncertainty.

Abstract

 

 The article analyzes in a pioneering way the degree of uncertainty of the pharmaceutical sector projects that received grant resources from FINEP between 2007 and 2014. We analyzed 87 projects from 60 companies included in 8 grant announcements. The data indicates an increase in the average value per project, as well as fluctuations over the period in the provision of resources, although it is a sector systematically contemplated by the recent industrial policies. From the taxonomy of uncertainty and types of innovation by Freeman and Soete, 52 projects in the pharmaceutical sector were classified. This analysis allowed to infer that, on average, the supported projects involve moderate uncertainty, pointing to the importance of systemic industrial policies that encourage Brazilian pharmaceutical companies to advance in development innovation activities with a greater degree of uncertainty. 

Downloads

Download data is not yet available.

Published

2021-01-01